𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postoperative complications after chemoradiation for advanced head and neck cancer

✍ Scribed by Eva Proctor; K. Thomas Robbins; Francisco Vieira; Catherine Hanchett; Grant Sommes

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
73 KB
Volume
26
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

To compare the rate of postoperative complications of patients with advanced head and neck cancer treated with the chemoradiation protocol β€œRADPLAT” with that of a similar cohort of patients treated with primary surgery.

Methods.

We retrospectively analyzed 50 patients treated with RADPLAT and 50 patients treated with primary surgery.

Results.

The rates of complications for local wound problems were 54% and 42%, respectively, for the RADPLAT cohort and the primary surgery cohort. However, the rate of local complications for the subset of RADPLAT patients undergoing clean‐contaminated surgery was 69% (p = .305). The rates of complications for medical (systemic) problems were 10% and 12%, respectively, for RADPLAT versus primary surgery patients. There was no significant difference in hospitalization time between the groups.

Conclusions.

Among patients with advanced head and neck cancer, surgical complications are high but not significantly different between patients undergoing the chemoradiation protocol β€œRADPLAT” and those undergoing primary surgery. Β© 2004 Wiley Periodicals, Inc. Head Neck 26: 272–277, 2004

πŸ“œ SIMILAR VOLUMES

Acceleration of hyperfractionated chemor
Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer
✍ Aaron M. Allen; Mohamed Elshaikh; Francis P. Worden; Carol R. Bradford; Theodoro πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 1 views

## Abstract ## Background. Our aim was to evaluate the acceleration of a hyperfractionated, concurrent chemoradiation regimen (HxCRT) for advanced head and neck squamous cell carcinoma (HNSCC). ## Methods. Patients with unresectable HNSCC were treated based on a previously published HxCRT regime

Low-dose weekly platinum-based chemoradi
Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer
✍ John M. Watkins; A. Jason Zauls; Amy H. Wahlquist; Keisuke Shirai; Elizabeth Gar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

Objectives/Hypothesis: The optimal concurrent chemoradiotherapy regimen for definitive treatment of locoregionally advanced head and neck cancer remains to be determined. The present investigation reports toxicities, disease control, patterns of failure, and survival outcomes in a large mature cohor

Complete hypopharyngeal obstruction by m
Complete hypopharyngeal obstruction by mucosal adhesions: A complication of intensive chemoradiation for advanced head and neck cancer
✍ Elizabeth J. Franzmann; Donna S. Lundy; Andre A. Abitbol; W. Jarrard Goodwin πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 119 KB

## Abstract ## Background. Severe swallowing dysfunction is the dominant long‐term complication observed in patients treated for head and neck squamous cell carcinoma (HNSCC) with treatment protocols using intensive concurrent chemotherapy with radiation therapy (chemo/XRT). We identified a subset

Tumor volume as prognostic factor in che
Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer
✍ Joost L. Knegjens; Michael Hauptmann; Frank A. Pameijer; Alfons J. Balm; Frank J πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 1 views

## Abstract ## Background Tumor volume is an important predictor of outcome in radiotherapy alone. Its significance in concomitant chemoradiation (CCRT) is much less clear. We analyzed the prognostic value of primary tumor volume for advanced head and neck squamous cell carcinoma (HNSCC) treated w